Cabio Biotech Wuhan Co Ltd
医疗健康 · 生物科技
Cabio Biotech (Wuhan) Co., Ltd. develops, produces, and markets arachidonic and docosahexaenoic acids, and beta-carotene for domestic and foreign infant formula, and healthy food manufacturers. It offers human and animal nutrition, personal care, and synthetic biology products. The company was founded in 1999 and is based in Wuhan, the People's Republic of China.
MARKET 市值 1.80B CNY PE 32.5x
52W ¥10.3 – ¥31.13
EODHD · Q 2026-03-31 · 同步 2026-07-12
QUALITY PEG — 营收 YoY -92.9%
▼ ROE 3.1% 营业利润率 -369.3% 净利润率 13.2%